L814-0676 Screening compound: 4-(propan-2-yl)-N-(4-{[1,2,4]triazolo[4,3-a]quinoxalin-4-yloxy}phenyl)benzene-1-sulfonamide

L814-0676 Screening compound: 4-(propan-2-yl)-N-(4-{[1,2,4]triazolo[4,3-a]quinoxalin-4-yloxy}phenyl)benzene-1-sulfonamide
L814-0676 Screening compound: 4-(propan-2-yl)-N-(4-{[1,2,4]triazolo[4,3-a]quinoxalin-4-yloxy}phenyl)benzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L814-0676
4-(propan-2-yl)-N-(4-{[1,2,4]triazolo[4,3-a]quinoxalin-4-yloxy}phenyl)benzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L814-0676

Molecular Formula

C24H21N5O3S (C24 H21 N5 O3 S)

Compound Name

4-(propan-2-yl)-N-(4-{[1,2,4]triazolo[4,3-a]quinoxalin-4-yloxy}phenyl)benzene-1-sulfonamide

IUPAC name

4-(propan-2-yl)-N-(4-{[124]triazolo[43-a]quinoxalin-4-yloxy}phenyl)benzene-1-sulfonamide

SMILES

CC(C)c(cc1)ccc1S(Nc(cc1)ccc1Oc1nc(cccc2)c2n2c1nnc2)(=O)=O

InChI

InChI=1S/C24H21N5O3S/c1-16(2)17-7-13-20(14-8-17)33(30,31)28-18-9-11-19(12-10-18)32-24-23-27-25-15-29(23)22-6-4-3-5-21(22)26-24/h3-16,28H,1-2H3

InChI Key

MOGCSQWRSAACBF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27476935

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

459.53

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.970

Distribution Coefficient, logD

4.947

Water Solubility, LogSw

-4.66

Polar Surface Area

78.681

Acid Dissociation Constant (pKa)

8.67

Base Dissociation Constant (pKb)

2.02

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

12.50

L814-0676 in Drug Discovery

Included in Screening Libraries

C-Met Library (15277 compounds)

Lipid Metabolism Library (9174 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Cardiovascular
  • Metabolic
Targets:
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L814-0676 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L814-0676?
Check Price and Availability of L814-0676, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L814-0676 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L814-0676
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L814-0676
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L814-0676 available by request